Ceptur Therapeutics’ $75 Million Series A Financing

Martina Bellini
Tagged:

Covington & Burling advised Ceptur Therapeutics on the deal.Ceptur Therapeutics, Inc., a biotechnology company focused on developing targeted oligonucleotide therapeutics based on U1 Adaptor technology, announced the…

This content is for Standard 1 Year members only.
Login Join Now
Martina Bellini

Author: Martina Bellini

…

This content is for Standard 1 Year members only.
Login Join Now